On Monday, Alphatec Holdings earned an upgrade to its Relative Strength (RS) Rating, from 80 to 83.
IBD's unique RS Rating identifies technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Decades of market research shows that the stocks that go on to make the biggest gains often have an 80 or better RS Rating in the early stages of their moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
Alphatec Holdings is not currently near a potential buy zone. See if the stock goes on to build a base that could ignite a new run.
The company showed 0% EPS growth in the latest quarterly report, while sales growth came in at 27%. Keep an eye out for the company's next round of numbers on or around Feb. 26.
The company holds the No. 42 rank among its peers in the Medical-Products industry group. Boston Scientific, Penumbra and Insulet are among the top 5 highly rated stocks within the group.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
